BridgeBio Pharma BBIO Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $882.02M+62.5% | $170.49M-75.0% | $645.1M+58.2% | $748.95M+83.6% | $542.74M+14.2% | ||
| $60.3M— | —— | —— | —— | —— | ||
| $205.23M+78.0% | $139.44M+2,853% | $116.52M+64,121% | $76.87M+133% | $115.27M-50.7% | ||
| $102.54M+2,493% | $73.51M— | $46.76M— | $22.23M— | $3.95M— | ||
| $1.24B+78.6% | $797.75M+10.7% | $839.38M+88.8% | $912.28M+48.0% | $695.17M-11.3% | ||
| $4.94M-26.2% | $5.37M-23.5% | $5.83M-33.0% | $6.11M-37.9% | $6.7M-41.3% | ||
| $27.36M-1.6% | $28.08M+17.3% | $28.8M+17.4% | $29.51M+17.5% | $27.8M+8.1% | ||
| $1.37B+55.5% | $936.03M+1.8% | $998.25M+50.1% | $1.08B+36.0% | $881.64M+3.8% | ||
| $110.12M+60.5% | $108.59M+137% | $81.98M+74.9% | $76.64M+102% | $68.63M+189% | ||
| $6.12M-65.1% | $7.19M-50.8% | $9.09M-51.2% | $14.67M-13.5% | $17.51M-12.0% | ||
| —— | —— | —— | —— | —— | ||
| $816.37M+437% | $287.97M+86.5% | $216.6M+55.6% | $175.85M+30.9% | $152.11M+7.5% | ||
| —— | —— | $2.01B+360% | $0-100% | $0-100% | ||
| $3.64B+44.4% | $3.01B+26.7% | $2.92B+55.1% | $2.86B+52.3% | $2.52B+33.6% | ||
| 500M+253,707% | 500M+255,002% | 500M+256,310% | 198K+2.1% | 197K+2.1% | ||
| -$3.99B-22.1% | -$3.82B-23.4% | -$3.63B-28.2% | -$3.45B-29.1% | -$3.26B-25.7% | ||
| -$2.28B-38.2% | -$2.09B-42.1% | -$1.93B-57.2% | -$1.79B-63.6% | -$1.65B-57.1% | ||
| $1.37B+55.5% | $936.03M+1.8% | $998.25M+50.1% | $1.08B+36.0% | $881.64M+3.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BridgeBio Pharma's total assets?
- BridgeBio Pharma (BBIO) holds $1.4B in total assets, up 55.5% year over year.
- How much debt does BridgeBio Pharma have?
- BridgeBio Pharma carries $3.3B in total debt against -$2.3B of shareholders' equity, a debt-to-equity ratio of 1.97.
- How much cash does BridgeBio Pharma have?
- BridgeBio Pharma holds $882.0M in cash and equivalents.
- Can BridgeBio Pharma cover its short-term obligations?
- Its current ratio is 1.52 — current assets exceed current liabilities.
- Where does BridgeBio Pharma's balance sheet data come from?
- Every line is extracted from BridgeBio Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
